Inpatient and Outpatient Differences in Pediatric Patients with Laboratory-confirmed COVID-19

Alicen B Spaulding1, David Watson1, Laura Norton2

  • 1From the Research Institute, Children's Minnesota, Minneapolis, MN.

Insights

In a study of over 30,000 pediatric COVID-19 cases, 5.2% required hospitalization. Black/African American and Hispanic/Latinx children were disproportionately represented among inpatients.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic significantly impacted pediatric populations globally.
  • Understanding demographic disparities in pediatric COVID-19 outcomes is crucial for targeted public health interventions.

Purpose of the Study:

  • To analyze the characteristics and demographic distribution of pediatric patients with laboratory-confirmed COVID-19.
  • To identify potential disparities in inpatient versus outpatient encounters among pediatric COVID-19 cases.

Main Methods:

  • Retrospective analysis of electronic health records from 40 US healthcare organizations.
  • Inclusion criteria: pediatric patients with laboratory-confirmed COVID-19.
  • Data collected on encounter type (inpatient vs. outpatient), age, sex, and race/ethnicity.

Main Results:

  • A total of 30,286 pediatric encounters with COVID-19 were analyzed.
  • 1586 (5.2%) encounters were classified as inpatient.
  • Significant variations in encounter types were observed by age and sex.
  • The proportion of Black/African American inpatients was significantly higher compared to outpatients.
  • Hispanic/Latinx children constituted nearly one-fourth of all pediatric COVID-19 patients.

Conclusions:

  • Pediatric COVID-19 encounters exhibit demographic variations, with notable differences between inpatient and outpatient settings.
  • Racial and ethnic disparities exist, with Black/African American and Hispanic/Latinx children being disproportionately affected, particularly in inpatient settings.
  • These findings underscore the need for culturally sensitive and equitable healthcare strategies to address COVID-19 in diverse pediatric populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
855
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
720
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
46